Toggle navigation
Home
Search
Services
Blog
Contact
About
Rapid Confirmatory Lyme Disease Test
Levin, Andrew E.
Immunetics, Inc., Boston, MA, United States
Search 102 grants from Andrew Levin
Search grants from Immunetics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Computational tools for mass spectrometry-based interactome data
The Role of CD5 in B-Cell Development and Autoimmunity
Diversity in Biomedical Careers via a BioScience Sharium
Regulation of Hepatic Cholesterol Ester Metabolism
Regulation of Protein Kinase C
Recently added grants:
Heat-shock protein 90 modulates goblet cell metaplasia in human airway epithelia
Role of ANO1 Channels and Its Regulation by PIP2 in EC-Coupling in Pulmonary Artery Myocytes
Acoustic System for Diagnosis of Pneumonia and Pneumothorax using Transfer Function Analysis
VITAL Start (Video-intervention to Inspire Treatment Adherence for Life): Brief facility based video intervention to improve retention and adherence to ART among pregnant and breastfeeding women
Dose Determination Trial for Implementing Evidence-Basedbehavioral Interventions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44AI040849-02
Application #
2005404
Study Section
Special Emphasis Panel (ZRG5-MBC-1 (02))
Project Start
1997-09-15
Project End
1999-08-31
Budget Start
1997-09-15
Budget End
1998-08-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Immunetics, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02210
Related projects
NIH 1998
R44 AI
Rapid Confirmatory Lyme Disease Test
Levin, Andrew E. / Immunetics, Inc.
NIH 1997
R44 AI
Rapid Confirmatory Lyme Disease Test
Levin, Andrew E. / Immunetics, Inc.
Comments
Be the first to comment on Andrew Levin's grant